LCCDEs EGFR induce tolerogenic dendritic cells and tumor antigen-specific regulatory T cells (Treg) to inhibit anti-tumor function of CD8+ T cells and thus promote lung cancer growth [117, 118]. This evidence concerns the gene EGFR and neoplasm.